Clinical Trials Browser

INDUSTRY × Leukemia × Arsenic Trioxide × Clear all

Leukemia, Leukemia, Promyelocytic, Acute

NCT00020969 2020-10-05

Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Clinical Trials

LATITUDE

Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes